Peak Bio, Inc. financial data

Location
4900 Hopyard Road, Suite 100, Pleasanton, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7.62 % -41.4%
Debt-to-equity -109 % +11.2%
Return On Equity 16.2 % -87.4%
Return On Assets -179 % +68.2%
Operating Margin -8.29K % -168%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.1M shares +5.58%
Common Stock, Shares, Outstanding 23.1M shares +2.17%
Entity Public Float 17M USD -70%
Common Stock, Value, Issued 2.31K USD +2.17%
Weighted Average Number of Shares Outstanding, Basic 23.1M shares +6.87%
Weighted Average Number of Shares Outstanding, Diluted 28.4M shares -20.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 75.2K USD -86.4%
Research and Development Expense 281K USD -86.7%
General and Administrative Expense 6.03M USD -50%
Operating Income (Loss) -6.23M USD +63.6%
Nonoperating Income (Expense) 2.91M USD +31.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.8M USD +2.56%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -3.32M USD +82.6%
Earnings Per Share, Basic 0 USD/shares +86.7%
Earnings Per Share, Diluted 0 USD/shares +86.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 862K USD +813%
Assets, Current 1.54M USD +22.1%
Property, Plant and Equipment, Net 27.5K USD -85.2%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 11.1K USD +123%
Assets 1.64M USD +8.38%
Accounts Payable, Current 5.36M USD -5.75%
Accrued Liabilities, Current 4.5M USD +44.1%
Liabilities, Current 22.4M USD +19.7%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 22.5M USD +18.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 110K USD -15.4%
Retained Earnings (Accumulated Deficit) -41M USD -8.83%
Stockholders' Equity Attributable to Parent -20.9M USD -19%
Liabilities and Equity 1.64M USD +8.38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.42M USD +1.56%
Net Cash Provided by (Used in) Financing Activities 1.11M USD -3.17%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 23.1M shares +2.17%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 922K USD +497%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50.9K USD
Deferred Tax Assets, Valuation Allowance 16M USD -44.5%
Deferred Tax Assets, Gross 16.1M USD -46.4%
Operating Lease, Liability 4.35M USD
Depreciation 31.8K USD -23.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.3M USD +82.6%
Lessee, Operating Lease, Liability, to be Paid 5.07M USD
Property, Plant and Equipment, Gross 753K USD -11.2%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.19M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 723K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.26M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 422K USD
Operating Lease, Payments 177K USD -77.5%
Additional Paid in Capital 19.9M USD +0.01%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 16M USD -44.5%
Share-based Payment Arrangement, Expense -69.3K USD -114%
Interest Expense 2.44M USD +121%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%